410 related articles for article (PubMed ID: 15712375)
41. Ovarian cancer: can we make the clinical diagnosis earlier?
Smith LH; Morris CR; Yasmeen S; Parikh-Patel A; Cress RD; Romano PS
Cancer; 2005 Oct; 104(7):1398-407. PubMed ID: 16116591
[TBL] [Abstract][Full Text] [Related]
42. Cigarette smoking and risk of breast carcinoma in situ.
Trentham-Dietz A; Nichols HB; Egan KM; Titus-Ernstoff L; Hampton JM; Newcomb PA
Epidemiology; 2007 Sep; 18(5):629-38. PubMed ID: 17700252
[TBL] [Abstract][Full Text] [Related]
43. Differential expression of prognostic factors and effect on survival in young (< or =40) breast cancer patients: a case-control study.
Hartley MC; McKinley BP; Rogers EA; Kalbaugh CA; Messich HS; Blackhurst DW; Lokey JS; Trocha SD
Am Surg; 2006 Dec; 72(12):1189-94; discussion 1194-5. PubMed ID: 17216817
[TBL] [Abstract][Full Text] [Related]
44. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
45. Axillary lymph node micrometastases in invasive breast cancer: national figures on incidence and overall survival.
Grabau D; Jensen MB; Rank F; Blichert-Toft M
APMIS; 2007 Jul; 115(7):828-37. PubMed ID: 17614850
[TBL] [Abstract][Full Text] [Related]
46. Incidence and risk factors for the occurrence of non-AIDS-defining cancers among human immunodeficiency virus-infected individuals.
Burgi A; Brodine S; Wegner S; Milazzo M; Wallace MR; Spooner K; Blazes DL; Agan BK; Armstrong A; Fraser S; Crum NF
Cancer; 2005 Oct; 104(7):1505-11. PubMed ID: 16104038
[TBL] [Abstract][Full Text] [Related]
47. Hormone receptor status and survival in a population-based cohort of patients with breast carcinoma.
Grann VR; Troxel AB; Zojwalla NJ; Jacobson JS; Hershman D; Neugut AI
Cancer; 2005 Jun; 103(11):2241-51. PubMed ID: 15844176
[TBL] [Abstract][Full Text] [Related]
48. The association between 3-hydroxy-3-methylglutaryl conenzyme A inhibitor use and breast carcinoma risk among postmenopausal women: a case-control study.
Boudreau DM; Gardner JS; Malone KE; Heckbert SR; Blough DK; Daling JR
Cancer; 2004 Jun; 100(11):2308-16. PubMed ID: 15160333
[TBL] [Abstract][Full Text] [Related]
49. Breast carcinoma chemoprevention in the community setting. Estimating risks and benefits.
Brewster AM; Christo DK; Lai H; Helzlsouer K
Cancer; 2005 Mar; 103(6):1147-53. PubMed ID: 15674856
[TBL] [Abstract][Full Text] [Related]
50. Estrogen replacement therapy for menopausal women with a history of breast carcinoma: results of a 5-year, prospective study.
Vassilopoulou-Sellin R; Cohen DS; Hortobagyi GN; Klein MJ; McNeese M; Singletary SE; Smith TL; Theriault RL
Cancer; 2002 Nov; 95(9):1817-26. PubMed ID: 12404273
[TBL] [Abstract][Full Text] [Related]
51. Male breast carcinoma in Israel: higher incident but possibly prognosis in Ashkenazi Jews.
Brenner B; Fried G; Levitzki P; Rakowsky E; Lurie H; Idelevich E; Neuman A; Kaufman B; Sulkes J; Sulkes A
Cancer; 2002 Apr; 94(8):2128-33. PubMed ID: 12001108
[TBL] [Abstract][Full Text] [Related]
52. Prognostic factors of early distant recurrence in hormone receptor-positive, postmenopausal breast cancer patients receiving adjuvant tamoxifen therapy: results of a retrospective analysis.
Debled M; MacGrogan G; Brouste V; Mathoulin-Pelissier S; Durand M; Mauriac L
Cancer; 2007 Jun; 109(11):2197-204. PubMed ID: 17450590
[TBL] [Abstract][Full Text] [Related]
53. [Clinical features and prognosis of multiple primary tumors of lung combined with other organs--report of 281 cases].
Yi SZ; Zhang DC; Wang YG; Sun KL
Ai Zheng; 2006 Jun; 25(6):731-5. PubMed ID: 16764770
[TBL] [Abstract][Full Text] [Related]
54. Abstracting height and weight from medical records, and breast cancer pathologic factors.
McEligot AJ; Im T; Dillman RO; West JG; Salem R; Haque R; Anton-Culver H
Cancer Causes Control; 2008 Dec; 19(10):1217-26. PubMed ID: 18618281
[TBL] [Abstract][Full Text] [Related]
55. Malignant melanoma in pregnancy. A population-based evaluation.
O'Meara AT; Cress R; Xing G; Danielsen B; Smith LH
Cancer; 2005 Mar; 103(6):1217-26. PubMed ID: 15712209
[TBL] [Abstract][Full Text] [Related]
56. Plasma carotenoids and recurrence-free survival in women with a history of breast cancer.
Rock CL; Flatt SW; Natarajan L; Thomson CA; Bardwell WA; Newman VA; Hollenbach KA; Jones L; Caan BJ; Pierce JP
J Clin Oncol; 2005 Sep; 23(27):6631-8. PubMed ID: 16170170
[TBL] [Abstract][Full Text] [Related]
57. A retrospective analysis of health care costs for bone fractures in women with early-stage breast carcinoma.
Zhou Z; Redaelli A; Johnell O; Willke RJ; Massimini G
Cancer; 2004 Feb; 100(3):507-17. PubMed ID: 14745866
[TBL] [Abstract][Full Text] [Related]
58. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience.
Santiago RJ; Harris EE; Qin L; Hwang WT; Solin LJ
Cancer; 2005 Jun; 103(12):2447-54. PubMed ID: 15887223
[TBL] [Abstract][Full Text] [Related]
59. Gallbladder pathology in morbid obesity.
Dittrick GW; Thompson JS; Campos D; Bremers D; Sudan D
Obes Surg; 2005 Feb; 15(2):238-42. PubMed ID: 15802067
[TBL] [Abstract][Full Text] [Related]
60. Effect of axillary lymphadenectomy on breast carcinoma survival.
Joslyn SA; Konety BR
Breast Cancer Res Treat; 2005 May; 91(1):11-8. PubMed ID: 15868427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
